Hasil Pencarian
Ditemukan 149 dokumen dengan kata kunci 4887 Simpan CSV Simpan CSV
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report
No. Panggil: Annals of Oncology; Volume 24, No.3, Maret, 2013, p.702-709 | | Location: Perpustakaan FT |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer
No. Panggil: Annals of Oncology; Volume 24, No.3, Maret, 2013, p.710-718 | | Location: Perpustakaan FT |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer
No. Panggil: Annals of Oncology; Volume 24, No.7, Juli, 2013, p.1762-1769 | | Location: Perpustakaan FT |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Bevacizumab plus chemotherapy continued beyond first progression in patients withmetastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings†
No. Panggil: Annals of Oncology; Volume 24, No.9, September, 2013, p.2342-2349 | | Location: Perpustakaan FT |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group
No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1580-1587 | | Location: Perpustakaan FT |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma
No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1567-1573 | | Location: Perpustakaan FT |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma
No. Panggil: Annals of Oncology; Volume 24, No.3, Maret, 2013, p.609-617 | | Location: Perpustakaan FT |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial
No. Panggil: Annals of Oncology; Volume 24, No.9, September, 2013, p.2335-2341 | | Location: Perpustakaan FT |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial
No. Panggil: Annals of Oncology; Volume 24, No.7, Juli, 2013, p.1740-1748 | | Location: Perpustakaan FT |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma
No. Panggil: Annals of Oncology; Volume 24, No.3, Maret, 2013, p.609-617 | | Location: Perpustakaan FT |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Prev   1 2 3 4 5 6 7 8 9 10  Next